
Bought the ASTS dip. Then SpaceX deleted the floor.
SPCX is the new space ETF.

SPCX is the new space ETF.
At least in the US, politicians are selling 2:1 bs buying. Something is about to go down or they are getting ready to dump money into the Anthropic IPO. Or maybe to fund mid term campaigns. What are you guys thinking?
I've been digging through the numbers, and I think many investors are missing how important this upcoming earnings report could be.
The stock is roughly 20% below the August highs, yet the business appears stronger today than it was when the stock was setting records.
That disconnect is what makes this earnings report so interesting.
For a company still experiencing strong AI-driven storage demand, that is not an expensive valuation.
>In August, WDC traded above $500 while quarterly EPS was $3.56.
>
>Today, WDC trades around $397 while management is guiding for approximately $4.00 EPS.
>
>Earnings power is moving UP while the stock price moved DOWN.
| Quarter | EPS Estimate | EPS Actual | Beat |
|---|---|---|---|
| Q4 FY26 | $3.31 | $3.56 | +7.6% |
| Q3 FY26 | $2.40 | $2.72 | +13.3% |
| Q2 FY26 | $1.93 | $2.13 | +10.4% |
| Q1 FY26 | $1.59 | $1.78 | +11.9% |
| Q4 FY25 | $1.48 | $1.66 | +12.2% |
WDC has beaten earnings expectations in 5 consecutive quarters.
The question is no longer:
>"Can WDC beat estimates?"
The real question is:
>"Can management provide guidance strong enough to force analysts to raise FY27 estimates again?"
This is where things get interesting.
At first glance, that seems irrational.
But the market wasn't disappointed with the results.
The market was disappointed relative to extremely high expectations.
The stock had already gone nearly parabolic heading into those reports.
When expectations become perfect, even excellent earnings can turn into a sell-the-news event.
✅ Stock near highs
✅ AI trade crowded
✅ Sentiment extremely bullish
✅ Expectations sky-high
✅ Stock down more than 20% from highs
✅ Sentiment significantly weaker
✅ Expectations reset
✅ Valuation far more reasonable
That's a much healthier setup going into earnings.
If WDC reports:
Then investors may begin re-rating the stock again.
Remember:
>WDC is no longer being valued like an unstoppable AI winner.
>
>The stock has already been derated.
>
>That lowers the hurdle considerably.
| Quarter | Next-Day Move |
|---|---|
| Aug 2026 | -13.0% |
| Apr 2026 | -0.7% |
| Jan 2026 | -10.1% |
| Oct 2025 | +8.8% |
One thing is clear:
WDC tends to move BIG after earnings.
There is very little history of this stock simply drifting after a report.
I don't think bulls need a perfect quarter.
They simply need confirmation of four things:
If those four points are confirmed, the market may start focusing on earnings growth again rather than the recent stock decline.
This is the most bullish data point to me:
The stock is down more than 20%.
Expected earnings are up.
Sooner or later, one of those has to adjust.
Disclosure: Long WDC.
What am I missing? I'd genuinely like to hear the bear case.
”you hang up…” ☺️ 🇷🇺
“No you hang up” 😊 🇺🇸
Most people who followed $CYDY remember March 30, 2021. The FDA publicly stated that CytoDyn's claims about leronlimab were "misleading and not supported by the data", no benefit was shown in COVID-19 treatment trials. The stock dropped 25%+ that day.
What happened afterward was a class action lawsuit covering investors who held $CYDY between March 27, 2020 and March 30, 2022.
A $500,000 settlement has been reached and terms are now submitted to the court for approval.
Who qualifies?
Anyone who held $CYDY during the class period and suffered losses from the alleged misrepresentations about leronlimab's effectiveness for HIV and COVID-19.
Can I still apply?
Yes, you can submit your application now and it will be processed once claims filing officially opens after court approval.
If you were damaged by this don't forget to check your eligibility. GL!
Iran is close to collapse 🇺🇸 💪